Shuji Ogino

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Shuji Ogino

Oct 20, 2024, 17:11 | Blog

Jonathan A. Nowak: KRAS G12C mutations are predictive of response in CRCs

Jonathan A. Nowak, Molecular and Gastrointestinal Pathologist at Brigham and Women’s Hospital and the Dana-Farber Cancer…

Aug 3, 2024, 13:04 | Insight

Piotr Wysocki: Aspirin reduces the risk of colorectal cancer in individuals with unhealthy lifestyle

Piotr Wysocki shared on LinkedIn: "A study published in JAMA Oncology investigated the association between…

Jul 10, 2024, 15:30 | Blog

Hagen Kennecke: First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer

Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023